Position in ERAS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$3,880,950
New position
Shares Held
239,861
first reported quarter
Ownership
0.077%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 87.73039385310659.ToString("F0")%
Shared 0.ToString("F0")%
None 12.269606146893409.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026STEMPOINT CAPITAL LP holds $493,288,963 across 62 Biotechnology names. ERAS ranks #39 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
1,035,496 | $50,904,983 | |
| 2 | ABVX |
Abivax S.A.
|
313,791 | $34,940,627 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
1,215,743 | $28,399,756 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
281,632 | $27,388,712 | |
| 5 | IMVT |
Immunovant, Inc.
|
746,494 | $18,542,910 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
56,267 | $18,128,664 | |
| 7 | SRZN |
Surrozen, Inc./DE
|
525,639 | $15,311,863 | |
| 8 | MBX |
MBX Biosciences, Inc.
|
499,469 | $14,909,149 |
All Filings in ERAS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,880,950 | 239,861 | Shares | Sole | 2026-05-18 | |
| No filing history on record for this holder in this stock. | ||||||